{"ticker": {"uuid": "51fc7235-96d6-49ff-ad2b-bbf62461378e", "symbol": "XVIVO", "name": "Xvivo Perfusion AB (publ)", "exchange": "STO", "country": "SE", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "AQR Capital Management no longer a public short seller in Xvivo Perfusion", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNWFo1VFRFN2t4OFpUWExibzRWRlJ5aGl1OThZaEx0VDNlUTc1aWI1OUZkdkRCWVpyWXZLejFta3Q3TTllVnlOeDlNX291Wm5XN2dCc2hseGRrSnhRaWJEUU44aGhjaElwZ1o2T2JmdlNsSWdlZjd2YVNoVEtFd1k1UFdIazlmWjZiQ1Z2MlUwZVJtQmc3d1dnM0F0S011WXhlZVFucE1jcDlZNXJSRGNNN0wySE1hMUVNMTNKcUYxMFJwc1R5?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-18T12:30:19+00:00", "published_display": "18 Jun 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Acadian Asset Management no longer a public short seller in Xvivo Perfusion", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOeVdMeHlpWWVYbHdOT2s2R3pwbkRLS0FZS21fZG9aTlZHUUZKajhQZ2JRR2Y1YjVveHRtR2Z3cUZ6THRXRWl3ai1HWE1VZi1qVndpS21hX2VzTmZralF4aWtjNXVXd0N2SWtjV2pkRFZ2RTE0aVMyblNQWkxyendoV2t2OThZblYzSWo1Ym9fX0xydWNHZTdTYXFhWFZESk9YNGpFX3NPNnNDVTR3T19tNmE5X0E3cllITUQ2Z21rcjJnX0ZPVkln?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-09T14:47:15+00:00", "published_display": "09 Jun 2026 14:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Xvivo remains a buy according to SHB - stock now a growth play", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxQX1FPaEFINll0TlhuSUlORV9kWGRSLV9hd0VBMG5VNlE3dnN6Y25NUjdxWnpfc2Z3UmMyY2xGRmpRUnhMeWZlYzVmZ1JyOXVZdXZlUXVpbEtMZVRxMDVEc3pqS2Q3NmJTbk9UYVlNb0hLeDRYNGdISEUtUTlfRUNMNy1sdXNFWDJaR1A4cHVwZ0RjMEE2MFRMNGViUTBrNUZHTW1STmlrQ2tYYzdYWktjTEU5VQ?oc=5", "source_name": "marketscreener.com", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPbEpndUZGZ2tna3VLYnZTUGE0aW9iR2V3VXRmNUdZdWxnbFRNYXRvVG5aUkFHSUtyVVRrX1BiU3B5eFNhVXNxTkUzMFNTV0h2UVltcHJXdXBMNTZoa3QtNEFZS2xfdUs3YXo1cXpNeFAxOHFiLTJ2TExrcGhFVHlqa24yZVpiNEx0SzJuVDlNa2JndXVhNnA0dklCSV9kMlpwekJrRQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Xvivo Perfusion Q4 Margin Compression Tests Bullish Growth Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Notice To Attend the Annual General Meeting in XVIVO Perfusion Ab (Publ)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxOM0hfMzg5aFNpN0ItRWhsWHpOQ2RqVW92QnNCaV82anJTOWtUeXlFQ25pS0kzTzFPTlZIZGJYUGpkR3B6SkFCWEtGazVwaWd2TGdRTkVLbTJtaDRMdzQ2eDRLa2t4VEVQTk9Mdm10T0RDTF95VU1LVDJaWFhmNlVoa2l1QlFYYVlWWWdGU0FDTTIzWnk4QmE3MVNsdjE0YjRqeUpN?oc=5", "source_name": "Market source", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Delay in CE Approval for XVIVO's Perfusion Solution for Heart Preservation", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNTWN1Y0dtc1ZTMExmc2UyMWRFbHdCV2R5Y1luNloyTWNNRlAtZFhwUHU2SnlydUR5UzgyVHIyNGxqZzJHYkxnMUhkZHh3TTZkMzZVU29qSml0bUtCYzJraWhNSFZSOWt0Z1QwSmRKbzM3cUJMRmJyMlFuRzl2d1NSd0o2NEdOWDA?oc=5", "source_name": "Market source", "published_at": "2025-07-28T07:00:00+00:00", "published_display": "28 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XVIVO Honored with 2025 SACC-USA Business Award for Life-Saving Innovation and Growth in the U.S. Market", "summary": "", "url": "https://news.google.com/rss/articles/CBMifkFVX3lxTE1kYWNXM203ajk2elY5bnlhazhLenRzdDVQQUZja1ViV2l4aFhiSkY3ZTM3RXJCRXplQTczSlFYRXpuREphZXFPandsQ1NMaExUOUNRd045RV93MW9UV3NGN182Tk1YaEpvTE5Rbjl2LWZkSWtGLWk0dURpVEtDUQ?oc=5", "source_name": "Market source", "published_at": "2025-06-13T07:00:00+00:00", "published_display": "13 Jun 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Xvivo Perfusion AB: Target Price Consensus and Analysts Recommendations | XVIVO | SE0004840718", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNdHdPcjk3UW84blgtX3FfRWhKcDlYZnNiMDZMeWtIZnp2dzJRYThua3puTk91RDVQbXpYQk80WGtjSllSQ1RSWlplZGNZaEtQRU1NWW5KVkFGQ2xYVWhBa2JpZlIydTFkcjJ0SUFuS2MzTkFqdFJuWnptYVhwWTE2R0c5SkdZZ0hx?oc=5", "source_name": "marketscreener.com", "published_at": "2024-01-24T06:40:51+00:00", "published_display": "24 Jan 2024 06:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XVIVO Completes the Acquisition of the Machine and Perfusion Business from Avionord S.r.l.", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNR05NcTJFOFJPT2hvQlJUX0Zld2VTdWtDRUN0Rm1WNWw2eTdzVHZxajhlMW9XSXNRSG81XzJNdG1mR1Q2NkVQMm1yVGhvV1hQS3I3ZUNTVjZjY2NFUjFVc2hqbTlxaGU0MFZvZnRKR0ZQRFpBYUNWQlRJYW1RY19MUS1EUHFiejlqRGpvT19odTU2R3UxbWg3eFVR?oc=5", "source_name": "Market source", "published_at": "2022-11-30T08:00:00+00:00", "published_display": "30 Nov 2022 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XVIVO Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "", "url": "https://news.google.com/rss/articles/CBMiakFVX3lxTE5TRGNzUVhHX2ZDbTVnMXQ3Y0xpRUE1akVxbzJCd0MxNVVjem1fRmdzZ08xWW1SUHAzV09GcGxrT1pQZUxUbENhTGNfdHVZb2JWUklZZFF1dl9oRlVJSHFFb0RTZmFCMWtKWUE?oc=5", "source_name": "TradingView", "published_at": "2022-08-27T05:50:30+00:00", "published_display": "27 Aug 2022 05:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of Xvivo Perfusion AB (OMXSTO:XVIVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMibEFVX3lxTE1qSlMwRmhoOG9yS2JXczlxZzFDT0hyX21ONndSVW45dlJsWXMyRWtpNjlJTnJaYkVWTTVnRWp5M0s3NGJxQjRIaVlXYU96RXBadUNKOTZQeERzdDc1dGhDRHVteDBva1RLTXYxRw?oc=5", "source_name": "TradingView", "published_at": "2018-06-16T07:33:25+00:00", "published_display": "16 Jun 2018 07:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XVIVO Stock Price and Chart \u2014 OMXSTO:XVIVO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXkFVX3lxTFB0emxfN2hyLUNiZmFTSzVFenczd3QwLXlnVzYxYXYzYkVSZ3NWd2NGN21jUHl1aUlyeExoTUtMcmYwbVNXR0prdC10QVFORWtOMExJaGVDNDd6MVhhd3c?oc=5", "source_name": "TradingView", "published_at": "2018-04-14T02:06:52+00:00", "published_display": "14 Apr 2018 02:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "AQR Capital Management no longer a public short seller in Xvivo Perfusion", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNWFo1VFRFN2t4OFpUWExibzRWRlJ5aGl1OThZaEx0VDNlUTc1aWI1OUZkdkRCWVpyWXZLejFta3Q3TTllVnlOeDlNX291Wm5XN2dCc2hseGRrSnhRaWJEUU44aGhjaElwZ1o2T2JmdlNsSWdlZjd2YVNoVEtFd1k1UFdIazlmWjZiQ1Z2MlUwZVJtQmc3d1dnM0F0S011WXhlZVFucE1jcDlZNXJSRGNNN0wySE1hMUVNMTNKcUYxMFJwc1R5?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-18T12:30:19+00:00", "published_display": "18 Jun 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Acadian Asset Management no longer a public short seller in Xvivo Perfusion", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOeVdMeHlpWWVYbHdOT2s2R3pwbkRLS0FZS21fZG9aTlZHUUZKajhQZ2JRR2Y1YjVveHRtR2Z3cUZ6THRXRWl3ai1HWE1VZi1qVndpS21hX2VzTmZralF4aWtjNXVXd0N2SWtjV2pkRFZ2RTE0aVMyblNQWkxyendoV2t2OThZblYzSWo1Ym9fX0xydWNHZTdTYXFhWFZESk9YNGpFX3NPNnNDVTR3T19tNmE5X0E3cllITUQ2Z21rcjJnX0ZPVkln?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-09T14:47:15+00:00", "published_display": "09 Jun 2026 14:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Xvivo remains a buy according to SHB - stock now a growth play", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxQX1FPaEFINll0TlhuSUlORV9kWGRSLV9hd0VBMG5VNlE3dnN6Y25NUjdxWnpfc2Z3UmMyY2xGRmpRUnhMeWZlYzVmZ1JyOXVZdXZlUXVpbEtMZVRxMDVEc3pqS2Q3NmJTbk9UYVlNb0hLeDRYNGdISEUtUTlfRUNMNy1sdXNFWDJaR1A4cHVwZ0RjMEE2MFRMNGViUTBrNUZHTW1STmlrQ2tYYzdYWktjTEU5VQ?oc=5", "source_name": "marketscreener.com", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPbEpndUZGZ2tna3VLYnZTUGE0aW9iR2V3VXRmNUdZdWxnbFRNYXRvVG5aUkFHSUtyVVRrX1BiU3B5eFNhVXNxTkUzMFNTV0h2UVltcHJXdXBMNTZoa3QtNEFZS2xfdUs3YXo1cXpNeFAxOHFiLTJ2TExrcGhFVHlqa24yZVpiNEx0SzJuVDlNa2JndXVhNnA0dklCSV9kMlpwekJrRQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Xvivo Perfusion Q4 Margin Compression Tests Bullish Growth Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Notice To Attend the Annual General Meeting in XVIVO Perfusion Ab (Publ)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxOM0hfMzg5aFNpN0ItRWhsWHpOQ2RqVW92QnNCaV82anJTOWtUeXlFQ25pS0kzTzFPTlZIZGJYUGpkR3B6SkFCWEtGazVwaWd2TGdRTkVLbTJtaDRMdzQ2eDRLa2t4VEVQTk9Mdm10T0RDTF95VU1LVDJaWFhmNlVoa2l1QlFYYVlWWWdGU0FDTTIzWnk4QmE3MVNsdjE0YjRqeUpN?oc=5", "source_name": "Market source", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Delay in CE Approval for XVIVO's Perfusion Solution for Heart Preservation", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNTWN1Y0dtc1ZTMExmc2UyMWRFbHdCV2R5Y1luNloyTWNNRlAtZFhwUHU2SnlydUR5UzgyVHIyNGxqZzJHYkxnMUhkZHh3TTZkMzZVU29qSml0bUtCYzJraWhNSFZSOWt0Z1QwSmRKbzM3cUJMRmJyMlFuRzl2d1NSd0o2NEdOWDA?oc=5", "source_name": "Market source", "published_at": "2025-07-28T07:00:00+00:00", "published_display": "28 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XVIVO Honored with 2025 SACC-USA Business Award for Life-Saving Innovation and Growth in the U.S. Market", "summary": "", "url": "https://news.google.com/rss/articles/CBMifkFVX3lxTE1kYWNXM203ajk2elY5bnlhazhLenRzdDVQQUZja1ViV2l4aFhiSkY3ZTM3RXJCRXplQTczSlFYRXpuREphZXFPandsQ1NMaExUOUNRd045RV93MW9UV3NGN182Tk1YaEpvTE5Rbjl2LWZkSWtGLWk0dURpVEtDUQ?oc=5", "source_name": "Market source", "published_at": "2025-06-13T07:00:00+00:00", "published_display": "13 Jun 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Xvivo Perfusion AB: Target Price Consensus and Analysts Recommendations | XVIVO | SE0004840718", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNdHdPcjk3UW84blgtX3FfRWhKcDlYZnNiMDZMeWtIZnp2dzJRYThua3puTk91RDVQbXpYQk80WGtjSllSQ1RSWlplZGNZaEtQRU1NWW5KVkFGQ2xYVWhBa2JpZlIydTFkcjJ0SUFuS2MzTkFqdFJuWnptYVhwWTE2R0c5SkdZZ0hx?oc=5", "source_name": "marketscreener.com", "published_at": "2024-01-24T06:40:51+00:00", "published_display": "24 Jan 2024 06:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XVIVO Completes the Acquisition of the Machine and Perfusion Business from Avionord S.r.l.", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNR05NcTJFOFJPT2hvQlJUX0Zld2VTdWtDRUN0Rm1WNWw2eTdzVHZxajhlMW9XSXNRSG81XzJNdG1mR1Q2NkVQMm1yVGhvV1hQS3I3ZUNTVjZjY2NFUjFVc2hqbTlxaGU0MFZvZnRKR0ZQRFpBYUNWQlRJYW1RY19MUS1EUHFiejlqRGpvT19odTU2R3UxbWg3eFVR?oc=5", "source_name": "Market source", "published_at": "2022-11-30T08:00:00+00:00", "published_display": "30 Nov 2022 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XVIVO Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "", "url": "https://news.google.com/rss/articles/CBMiakFVX3lxTE5TRGNzUVhHX2ZDbTVnMXQ3Y0xpRUE1akVxbzJCd0MxNVVjem1fRmdzZ08xWW1SUHAzV09GcGxrT1pQZUxUbENhTGNfdHVZb2JWUklZZFF1dl9oRlVJSHFFb0RTZmFCMWtKWUE?oc=5", "source_name": "TradingView", "published_at": "2022-08-27T05:50:30+00:00", "published_display": "27 Aug 2022 05:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of Xvivo Perfusion AB (OMXSTO:XVIVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMibEFVX3lxTE1qSlMwRmhoOG9yS2JXczlxZzFDT0hyX21ONndSVW45dlJsWXMyRWtpNjlJTnJaYkVWTTVnRWp5M0s3NGJxQjRIaVlXYU96RXBadUNKOTZQeERzdDc1dGhDRHVteDBva1RLTXYxRw?oc=5", "source_name": "TradingView", "published_at": "2018-06-16T07:33:25+00:00", "published_display": "16 Jun 2018 07:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XVIVO Stock Price and Chart \u2014 OMXSTO:XVIVO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXkFVX3lxTFB0emxfN2hyLUNiZmFTSzVFenczd3QwLXlnVzYxYXYzYkVSZ3NWd2NGN21jUHl1aUlyeExoTUtMcmYwbVNXR0prdC10QVFORWtOMExJaGVDNDd6MVhhd3c?oc=5", "source_name": "TradingView", "published_at": "2018-04-14T02:06:52+00:00", "published_display": "14 Apr 2018 02:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 55, "total_relevant": 13, "sentiment_summary": {"positive": 3, "negative": 0, "neutral": 10, "score": 55, "total": 13, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 4.4, "count": 8}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 3, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 273.0, "latest_week": "2026-06-12", "one_week_move": -1.7, "four_week_move": -5.4, "twelve_week_move": 49.2, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.886993, "market_dynamics_buy_signal": false, "relative_strength": 17.477044, "fair_value_gap": -13.8, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 52.362, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.7% over one week, -5.4% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 65, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 5}, {"label": "marketscreener.com", "count": 4}, {"label": "TradingView", "count": 3}, {"label": "simplywall.st", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 13}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 8}, {"label": "Earnings", "count": 1}, {"label": "Regulatory and legal", "count": 1}, {"label": "Analyst action", "count": 1}, {"label": "Deals and strategy", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "13", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-1.7% over one week, -5.4% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "AQR Capital Management no longer a public short seller in Xvivo Perfusion"}], "updated_at": "2026-06-19T15:15:21.527277+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}